Moderately to Severely Active Crohn’s Disease
Moderately to severely active Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract that can cause symptoms like abdominal pain, diarrhea, and weight loss.
Psoriasis Treatment: CKD-704 vs. Skyrizi®
We are comparing a new biosimilar treatment for psoriasis with the approved Skyrizi® to see how safe it is and how well it works in healthy adults.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Moderate-to-Severe Plaque Psoriasis
Moderate-to-severe plaque psoriasis is a chronic autoimmune condition that leads to the rapid growth of skin cells, resulting in thick, red, scaly patches on the skin.
Active Psoriatic Arthritis
Active psoriatic arthritis is a type of inflammatory arthritis that affects some people with psoriasis, causing joint pain, stiffness, and swelling.
Moderately to Severely Active Ulcerative Colitis
Moderately to severely active ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the digestive tract, leading to symptoms like abdominal pain and diarrhea.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Mtz Clinical Research Powered By Pratia
Włochy, Poland
Sponsor: Chong Kun Dang Pharmaceutical Corp.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.